Professor Chan, See Ching 陳詩正
Professor Chan graduated from The University of Hong Kong with a degree of BDS in 1985 and that of MBBS in 1995. He joined the Department of Surgery for surgical training in 1996. Soon after his promotion to Consultant in 2007, he was appointed Clinical Professor of the University in 2011 and is now Chief of the Division of Liver Transplantation. He is a high achiever strongly committed to excellence and his accomplishments in all respects of his career have been exemplary.
Professor Chan has an innovative spirit in research. He completed 3 doctoral degrees viz. the Master of Surgery in 2005 and the Doctor of Philosophy in 2011, and Doctor of Medicine in 2013. He has enjoyed good collaborative relationships with local and international researchers as principal and co-investigators. He is a Principal Investigator of the University’s State Key Laboratory of Liver Research. Professor Chan has been a sustained contributor of high quality research evidenced by an impressive research output of 160 articles in first-class journals of high impact factors and 10 book chapters. Among his publications, 3 papers on living donor liver transplantation published in the Annals of Surgery and the American Journal of Transplantation respectively have been widely cited and made a significant impact to the transplant community. In 2005 he received the State Scientific and Technological Progress (SSTA) First-class Award from the National Office for Science and Technology Awards. On the ISI Essential Science Indictors 2012 and 2013, he is among the top 1% most cited scholars in Clinical Medicine. His recognition is evidenced by the regular invitations to speak at important local and international meetings, and his service on editorial board of prestigious journals including Hepatobiliary & Pancreatic Diseases International and World Journal of Transplantation and Liver Cancer.
On teaching, Professor Chan is a keen and engaging teacher and is well regarded. He spends a great effort on medical education and training of interns and junior surgeons. Lectures on liver transplantation and bioethics of organ transplantation are delivered regularly. He serves on the Quality Assurance Sub-committee of the Medical Curriculum of the Li Ka Shing Faculty of Medicine. He frequently lectures for various medical and nursing courses. Currently he supervises one PhD and one Master of Science candidates. He is also a mentor of 9 local and overseas liver transplant fellows at Queen Mary Hospital. His commitment has contributed much to the quality of education and training in the Department.
Professor Chan is an excellent surgeon of the highest standard of skills in liver transplantation. His past experience in maxillofacial surgery has been an asset to him in acquiring and perfecting the refined liver surgical skills. He contributed to the first sequential liver transplant for familial amyloidotic polyneuropathy in Hong Kong in 2006, the first living donor interchange liver transplant in Hong Kong in 2009, the liver graft sharing with Taiwan in 2010, and the first simultaneous heart-liver transplant and sequential liver transplant in Hong Kong in 2010. He is now one of the 5 surgeons who are able to perform both liver donor and recipient operations of international standard in Hong Kong, and is also among the top liver transplant surgeons in the Asia Pacific region. As a leader, his team provides a service of a calibre that is amongst the best in the world.
Professor Chan has established a remarkable reputation through his outstanding professional expertise and high-quality research. He is Vice President of the Hong Kong Society of Transplantation, Key Opinion Leader of the Transplantation Society, and Advisor to the Hong Kong Liver Transplant Patients’ Association. He represented the College of Surgeons of Hong Kong at the Legislative Council on the 2010 Amendment of Organ Transplant Ordinance. At Queen Mary Hospital he is a member of different committees for improvement of the clinical services. He is the current President of the Hong Kong Society of Transplantation.
4 selected publications:
1. Chan SC, Fan ST, Lo CM et al. Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg 2007; 245:110-117. (This paper established the standard of care for donors of our center which initiated and first developed donor right hepatectomy which is now the most common donor procedure for adult living donor liver transplantation in the world.)
2. Chan SC, Fan ST, L CM, Liu SL, et al. A Decade of Right Live Adult-to-Adult Living Donor Liver Transplantation - the Recipient Mid-term Outcomes. Ann Surg 2008; 248:411 (This paper describes the standard of care for recipients of our center which initiated adult living donor liver transplantation in the world.)
3. Chan SC, Lo CM, Ng KK et al. Alleviating the burden of small-for-size graft in right liver living donor liver transplantation through accumulation of experience. Am J Transplant 2010; 10:859-867. (This study provides strong evidence of improvement of recipient surgical outcomes despite graduate decrease in partial liver graft size with maturation of a center which also pioneered living donor liver transplantation.)
4. Chan SC, Lo CM, Ng KK et al. Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein. Liver Transpl 2011; 17:115-121. (This prospective study on visceral hemodynamics in living donor liver transplantation illustrates the importance of achieving a low to moderate portal pressure in stead of portal flow in the success right liver living donor liver transplantation including the middle hepatic vein.)
|Awardees||Award Date||Honours / Awards / Prizes||Category|
|2014-06-01||The 2014 Joint International Congress of ILTS, ELITA, & LICAGE, London, UK - Young Investigators Award for Histological Outcome after Liver Transplantation for Chronic Hepatitis B using Oral Antiviral Therapy Alone: International Liver Transplant Society||Research Achievement|
|2014-03-01||Best Oral Presentation Award (Abstract titled "Outcomes of liver resection for hepatocellular carcinoma with obstructive jaundice"): The 11th World Congress of the International Hepato-Pancreato-Biliary Association, Seoul, Korea, 22-27 March 2014||Research Achievement|
|2014-07-01||Poster of Distinction, World Transplant Congress 27-31 July 2014 (Abstract entitled " Excellent outcomes of severe steatotic grafts in liver transplantation"): World Transplant Congress 2014||Research Achievement|
|2005-12-01||First-class Award of the Chinese State Scientific and Technological Progress Award||Research Achievement|
|2006-07-01||10 Years' Long Service Award: Hospital Authority, Hong Kong||Others|
|2011-01-01||Outstanding Staff and Teams Award 2011: Merit Award, Hospital Authority, Hong Kong||Others|
|2011-05-01||The 2011 Joint International Congress of ILTS, ELITA, & LICAGE, San Francisco, USA - Young Investigators Award for Entecavir vs Lamivudine Prophylaxis without Hepatitis B Immune Globulin after Liver Transplantation for Chronic Hepatitis B: International Liver Transplant Society||Research Achievement|
|2012-07-01||Distinguished Research Paper Award for Young Investigators for Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation: Hong Kong College of Physicians||Research Achievement|
|2007-06-20||Travelling Award: The International Liver Transplantation Society 13th Annual International Congress, Rio de Janeiro, Brazil, 20 - 23 June 2007||Research Achievement|
|2012-05-01||Acute phase circulating microRNAs predict tumor recurrence and survivals of hepatocellular carcinoma patients after liver transplantation: Young Investigator Award, the 18th Annual International Congress of the International Liver Transplantation Society, San Francisco, California, U.S.A., 16 - 19 May 2012||Research Achievement|
|2011-01-01||Outstanding Staff 2011: Hong Kong West Cluster and Queen Mary Hospital, Hospital Authority, Hong Kong||Others|
|2015-11-01||Travel Grant Award ("NLRP3 inflammasome initiated liver graft injury through telomere-independent repressor activator protein1 (RAP1) / keratinocyte chemoattractant (KC) axis"): Transplantation Science Symposium of The Transplantation Society, Lorne, Australia, 11-13 November 2015||Research Achievement|
|Term Period||Position||Professional Societies|
|04/2013 - 04/2015||President||Hong Kong Society of Transplantation|
Are You Missing Publications, Invited Lectures? Click Me.